VTN and neoplasm: Although heterogeneous relative to tumor type, complement proteins expressed by malignant cells are variable; in general, tumor cells express low C8 and C9 but highly express C3 and the regulators factor H, factor I and especially the membrane regulators CD46, CD55 and CD59 [19].